Amcinonide

Inflammation, Skin Diseases, Itching

Treatment

20 Active Studies for Amcinonide

What is Amcinonide

Amcinonide

The Generic name of this drug

Treatment Summary

Amcinonide is a steroid medication used to reduce inflammation and treat certain skin conditions.

Cyclocort

is the brand name

Amcinonide Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Cyclocort

Amcinonide

1999

6

Effectiveness

How Amcinonide Affects Patients

Amcinonide is a type of steroid medicine used to reduce inflammation and reduce itching. The exact way it works is unknown, but scientists believe it helps control certain chemicals in the body that cause swelling and irritation. It usually comes as an ointment, and can also help the skin stay hydrated.

How Amcinonide works in the body

Topical steroids, like amcinonide, reduce inflammation. It is believed that this is achieved by blocking the release of arachidonic acid, which is a precursor for inflammatory molecules like prostaglandins and leukotrienes. Amcinonide has a strong affinity for the glucocorticoid receptor but only weak affinity for progesterone, mineralocorticoid, estrogen, and androgen receptors.

When to interrupt dosage

The advised dosage of Amcinonide is predicated upon the diagnosed affliction, including Inflammation, corticosteroid-responsive dermatoses and Itch. The quantity of dosage is contingent upon the technique of administration (e.g. Cream - Topical or Lotion) featured in the table below.

Condition

Dosage

Administration

Inflammation

, 0.001 mg/mg, 0.1 %

, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Lotion - Topical, Lotion

Skin Diseases

, 0.001 mg/mg, 0.1 %

, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Lotion - Topical, Lotion

Itching

, 0.001 mg/mg, 0.1 %

, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Lotion - Topical, Lotion

Warnings

There are 20 known major drug interactions with Amcinonide.

Common Amcinonide Drug Interactions

Drug Name

Risk Level

Description

Allogeneic processed thymus tissue

Minor

The therapeutic efficacy of Allogeneic processed thymus tissue can be decreased when used in combination with Amcinonide.

Inebilizumab

Minor

The risk or severity of infection can be increased when Amcinonide is combined with Inebilizumab.

Vibrio cholerae CVD 103-HgR strain live antigen

Minor

The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Amcinonide.

2,4-thiazolidinedione

Moderate

The risk or severity of hyperglycemia can be increased when Amcinonide is combined with 2,4-thiazolidinedione.

AICA ribonucleotide

Moderate

The risk or severity of hyperglycemia can be increased when Amcinonide is combined with AICA ribonucleotide.

Amcinonide Toxicity & Overdose Risk

A person is unlikely to experience any health risks from applying an excessive amount of the drug to their skin or accidentally swallowing it.

image of a doctor in a lab doing drug, clinical research

Amcinonide Novel Uses: Which Conditions Have a Clinical Trial Featuring Amcinonide?

200 active trials are being conducted to ascertain the effectiveness of Amcinonide in providing relief for Corticosteroid-responsive Dermatoses, Itch and Inflammation.

Condition

Clinical Trials

Trial Phases

Skin Diseases

0 Actively Recruiting

Itching

2 Actively Recruiting

Phase 3, Not Applicable

Inflammation

58 Actively Recruiting

Not Applicable, Early Phase 1, Phase 1, Phase 2, Phase 3, Phase 4

Amcinonide Reviews: What are patients saying about Amcinonide?

5

Patient Review

11/29/2009

Amcinonide for Genital Itching

3

Patient Review

2/10/2010

Amcinonide for Plaque Psoriasis

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about amcinonide

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Cyclocort used for?

"This medication is a strong corticosteroid that is used to treat various skin conditions, such as eczema, dermatitis, allergies, and rash. Amcinonide works by reducing the swelling, itching, and redness that can be associated with these conditions."

Answered by AI

What is Amcinonide cream used for?

"This medicine is a corticosteroid. It is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions."

Answered by AI

Is Cyclocort over the counter?

"Cyclocort is a prescription medicine used to treat the symptoms that are responsive to corticosteroids. Cyclocort may be used alone or with other medications."

Answered by AI

Clinical Trials for Amcinonide

Image of Exercise and Performance Nutrition Laboratory in Saint Charles, United States.

Multi-Strain Postbiotic for Inflammation and Gastrointestinal Symptoms

18 - 55
All Sexes
Saint Charles, MO

This study will evaluate the effects of a multi-strain postbiotic supplement on markers of inflammation, immune function, gastrointestinal symptoms, psychological well-being, and intestinal permeability in healthy adults. The primary objective is to determine whether four weeks of postbiotic supplementation alters physiological and perceptual responses to a standardized bout of moderate-to-high intensity exercise compared with placebo. Approximately 50 healthy men and women aged 18 to 55 years will be enrolled in a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Participants will be randomly assigned to receive either a multi-strain postbiotic supplement or a matched placebo for 28 days. At the end of the supplementation period, participants will complete a 45-minute treadmill exercise bout at 75% of their individually determined maximum heart rate. Blood samples will be collected to assess biomarkers of inflammation, immune activity, and recovery. Gastrointestinal symptoms, intestinal permeability, anxiety, and perceived recovery will be evaluated using validated questionnaires. This study is designed to determine whether postbiotic supplementation modulates physiological stress responses and subjective well-being following prolonged exercise in healthy adults.

Waitlist Available
Paid Trial

Exercise and Performance Nutrition Laboratory

Chad M Kerksick, PhD

Image of ATX Hyperbarics in Austin, United States.

Hyperbaric Oxygen Therapy for Cardiovascular Fitness

30 - 60
All Sexes
Austin, TX

The purpose of this study is to determine whether hyperbaric oxygen therapy (HBOT) at 1.75 atmospheres of pressure (ATA) improves cardiovascular fitness (VO₂ max) and reduces inflammation in healthy adults. HBOT involves breathing pure oxygen in a pressurized chamber and is considered investigational for this use. Recent research has shown that different HBOT pressures can have different effects on inflammation. Specifically, some inflammatory cytokines (measurable markers of inflammation in the body) appear to decrease at low pressures like 1.3 ATA, while a different set of cytokines responds better at higher pressures, such as 2.0 ATA. Cytokines are small proteins that play a crucial role in cell signaling, particularly within the immune system. They help regulate inflammation, infection response, and overall immune function. While some cytokines promote inflammation to fight off threats, others help reduce inflammation when it's no longer needed. An imbalance in cytokines - especially excessive inflammatory cytokines - can contribute to chronic inflammation, cardiovascular disease, and other health issues. In this study, we are testing an intermediate pressure - 1.75 ATA - to see if we can target both sets of cytokines at once. If successful, this approach could offer broader anti-inflammatory benefits. We are also interested in how this intermediate pressure may improve VO₂ max, a key indicator of cardiovascular fitness. Since VO₂ max is strongly linked to heart health and overall longevity, finding a safe and effective way to improve it has meaningful implications not just for athletes, but for anyone looking to enhance their fitness and well-being.

Recruiting
Has No Placebo

ATX Hyperbarics (+1 Sites)

Image of Montana State University in Bozeman, United States.

Haskap Berries for Exercise Performance Recovery

18 - 35
All Sexes
Bozeman, MT

The purpose of this clinical trial is to determine how certain food items affect oxidative stress, inflammation, and performance recovery from exercise induced muscle damage in a resistance trained population. The main questions The investigators aim to answer are the following: * Do Haskaps speed the recovery of oxidative stress and inflammation markers after an intense lower body workout in resistance trained adults? * Do Haskaps speed the recovery of performance measures after an intense lower body workout in resistance trained adults? * The data collected in this investigation may also be used to ask additional questions not yet identified. For example, the investigators may use the stored samples to evaluate how the blood metabolites of participants differ before and after intense exercise. These additional questions are called secondary analyses. Please note that no genetic analysis will be conducted and racial and ethnic differences among participants will not be used in any secondary analyses. Researches will compare Haskap juice to a color, flavor and carbohydrate matched placebo to see if Haskaps speed recovery in inflammation, oxidative stress and performance. * Participants will be asked to drink either Haskap juice or placebo and follow a low polyphenolic diet * Participants will perform an intense resistance workout * Participants will have their blood drawn before and after the workout * Performance will be analyzed at 24, 48 and 72 hours after the workout

Recruiting
Paid Trial

Montana State University

Mary P Miles

Image of Johns Hopkins Bayview Medical Center in Baltimore, United States.

VR-Enhanced PMR for Post-Burn Symptoms

18+
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are: * Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR? * Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will: * Complete home-based sessions of VR-enhanced PMR * Complete home-based sessions of standard PMR * Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study * Use VR equipment provided for the intervention period (during the VR-PMR arm)

Recruiting
Has No Placebo

Johns Hopkins Bayview Medical Center

Sheera Lerman Zohar, PhD

Have you considered Amcinonide clinical trials?

We made a collection of clinical trials featuring Amcinonide, we think they might fit your search criteria.
Go to Trials
Image of UConn Health in Farmington, United States.

Cognitive Remediation for Memory and Thinking Difficulties

18+
All Sexes
Farmington, CT

The goal of this clinical trial is to determine if a neuroscience-based computerized cognitive remediation ("brain training") program can treat neurocognitive dysfunction (i.e., memory or thinking difficulties) that emerges in some older adults following a viral infection. The main questions it aims to answer are: * Does computerized cognitive remediation improve cognitive performance and day-to-day functioning in older adults with postviral neurocognitive dysfunction? * Will treatment effects be maintained over time, leading to better long term cognitive outcomes? * Does the treatment lead to reductions in blood-based markers of inflammation as a potential mechanism of cognitive symptom improvement? * Can the treatment be optimized and refined based on feedback from participants to improve user (patient) experience? Researchers will compare the computerized cognitive remediation program to an active computer-based control condition (alternative computer activities) to see if the computerized cognitive remediation program works to treat postviral neurocognitive dysfunction. Participation takes approximately 43-48 hours over 7 months, with most activities (40-46 hours) completed within the first 7-8 weeks, including: * Initial intake visit: Eligibility confirmation (\~2-3 hours) * Computer activities: About 5 hours per week for \~6 weeks (total \~30 hours) completed on a computer tablet provided by the study and loaned to participants for use during the treatment phase * Weekly remote check-in meetings: \~30 minutes each during treatment * Blood draws: Two sessions (before and after treatment), \~20-30 minutes each * Three research visits: Pre-treatment, post-treatment, and 6-month follow-up (\~2-3 hours each, including assessments of cognitive, emotional, and daily functioning)

Recruiting
Has No Placebo

UConn Health

Cutter Lindbergh, Ph.D.

Have you considered Amcinonide clinical trials?

We made a collection of clinical trials featuring Amcinonide, we think they might fit your search criteria.
Go to Trials
Image of Abcentra Investigational Site in Los Angeles, United States.

Orticumab for Heart Attack

18+
All Sexes
Los Angeles, CA

The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarction who have elevated coronary inflammation based on CCTA. The main question it aims to answer is: Clinical effects of orticumab treatment on inflammation of the coronary artery parameters measured with CCTA Researchers will compare the effects with placebo group after 6 months of treatment Participants will Keep the planned study visit appointments Provide complete information about medical and medical history Speak to the study doctor before changing any of non-study treatments, including starting new medications, receiving any vaccinations, or setting out to join any other clinical studies

Phase 2
Recruiting

Abcentra Investigational Site (+6 Sites)

Abcentra

Image of School of Public Health in Bloomington, United States.

High Salt Intake for High Blood Pressure

60 - 85
All Sexes
Bloomington, IN

Most Americans consume excess dietary salt based on the recommendations set by the American Heart Association and Dietary Guidelines for Americans. High dietary salt impairs blood pressure control by affecting systemic blood vessels and the kidneys. These changes contribute to excess salt consumption being associated with increased risk for chronic kidney disease and cardiovascular disease, the leading cause of death in America. Salt is particularly deleterious in older adults who are more likely to exhibit salt-sensitive hypertension. However, salt consumption remains high in the United States. Thus, there is a critical need for strategies to counteract the effects of high dietary salt as consumption is likely not going to decrease. One promising option is ketones, metabolites that are produced in the liver during prolonged exercise and very low-calorie diets. While exercise and low-calorie diets are beneficial, not many people engage in these activities. Limited evidence indicates that ketone supplements improve cardiovascular health in humans. Additionally, published rodent data indicates that ketone supplements prevent high salt-induced increases in blood pressure, blood vessel dysfunction, and kidney injury. Our human pilot data also indicates that high dietary salt reduces intrinsic ketone production, but it is unclear whether ketone supplementation confers humans' protection against high salt similar to rodents. Therefore, the investigators seek to conduct a short-term high-dietary salt study to determine whether ketone supplementation prevents high dietary salt from eliciting increased blood pressure, blood vessel dysfunction, and kidney injury/impaired blood flow. The investigators will also measure inflammatory markers in blood samples and isolate immune cells that control inflammation. Lastly, the investigators will also measure blood ketone concentration and other circulating metabolites that may be altered by high salt, which could facilitate novel therapeutic targets to combat high salt.

Recruiting
Has No Placebo

School of Public Health

Image of Goldring Center for High Performance Sport in Toronto, Canada.

Physical Activity for Delayed Onset Muscle Soreness

18 - 35
All Sexes
Toronto, Canada

After completing novel activity or exercise we may experience exercise-induced muscle damage (EIMD), resulting in a period of reduced muscle function and delayed onset muscle soreness (DOMS). DOMS is characterized by muscle pain and tenderness that typically resolves within a week. While the precise cause of DOMS is unknown, there is growing evidence implicating damage to the connective tissue that surrounds our muscle fibers and is related to a small amount of inflammation. This inflammation is a normal part of our body's ability to recovery from injuries and may be visualized through the use of ultrasound technology. A variety of recovery techniques have been proposed that may help with the recovery of DOMS such as massage and electrical muscle stimulation, but these are not always accessible. Therefore, we are interested in investigating whether the number of daily steps can affect how you experience DOMS.

Waitlist Available
Has No Placebo

Goldring Center for High Performance Sport

Have you considered Amcinonide clinical trials?

We made a collection of clinical trials featuring Amcinonide, we think they might fit your search criteria.
Go to Trials